Regeneron partially stopped tests of drug used on Trump
The antibody cocktail will be discontinued for ventilated patients due to potential safety concerns and increased risks. In early October, President Donald Trump, who was ill with COVID-19, was injected with this drug.
The American company Regeneron Pharmaceuticals will stop testing its “cocktail” of antibodies on seriously ill coronavirus infection. This was reported by the press service of the company.
We are talking about the drug REGN-COV2, which is a set of antibodies to counteract the virus. US President Donald Trump was injected with this “cocktail” in early October when he contracted COVID-19.
Regeneron Pharmaceuticals said it has received a recommendation from the Independent Monitoring Committee (IDMC) to make changes to an ongoing study of hospitalized patients.
“IDMC recommends that further study enrollment be suspended for patients requiring high-flow oxygen or mechanical ventilation,” the report said. The recommendations are made due to the “potential safety issues and insufficient information about the risks” of the drug for people with severe coronavirus infection with lung damage.
Severely ill COVID-19 will not be injected with a “cocktail” until statistics on the treatment of other patients are received. REGN-COV2 trials will continue in outpatient patients.
The company sent this information to the US Food and Drug Administration (FDA). Now this body is deciding whether it will be possible to inject a “cocktail” of antibodies to patients in case of emergency.
After contracting the coronavirus on October 2, Trump was injected with the drug and then hospitalized. After that, the president promised US residents the same treatment that he received himself. At the same time, Trump said that he would make this treatment free.
The New York Times estimated that Trump’s treatment cost no less than $ 100,000. However, they did not mention an experimental drug from Regeneron Pharmaceuticals in their calculations.
Russian doctors said they would not rely on the experience of the American president’s treatment. The RAMS vaccinologist, Professor Mikhail Kostinov, said that the country “has its own scientific potential for both drugs and minds, so we don’t need it.”
Virologist Vitaly Zverev from the Russian Academy of Sciences said that Russian doctors have their own methods of treatment, based on the stage of the patient’s illness. “We have been talking about personalized medicine for a long time: schemes are schemes, but we need to take into account both chronic diseases and the state of health of the person we are treating,” he said.
Сообщение Regeneron partially stopped tests of drug used on Trump появились сначала на supercar.ru.